Fundz

Venatorx Pharmaceuticals reported raising $15 Million in an initial SEC Form D filing, from an offering of $16.4 Million

PRIVATEFeb 27, 2023

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale Feb 17, 2023)

Round Type

Venture

MalvernHealthcarePharmaceutical

Who to call at VenatoRx Pharmaceuticals, Inc., and when

A new round usually means VenatoRx Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VenatoRx Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VenatoRx Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VenatoRx Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VenatoRx Pharmaceuticals, Inc.

Location

30 SPRING MILL DRIVE

Malvern, Pennsylvania, United States

About

Venatorx Pharmaceuticals is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VenatoRx Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTimothy H., Executive Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VenatoRx Pharmaceuticals, Inc.'s next move

See what Strategic adds

VenatoRx Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.